Effective with dates of service on and after October 1, 2019, and in accordance with Empire’s Pharmacy and Therapeutic (P&T) process, Empire BlueCross BlueShield (“Empire”) will update its commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.


To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate.

Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).


To view a summary of changes, click on the attachment.  

Featured In:
October 2019 Empire Provider News